Home Contact Us 中文 English
Yourlocation:Home >News> Trimebutine maleate in non-ulcer dyspepsia

Trimebutine maleate in non-ulcer dyspepsia

Time:2015/9/30 7:23:05

Trimebutine maleate has been evaluated in several controlled studies in patients with non-ulcer dyspepsia (table 4).'06 - lob at oral doses ranging from 400 to 600 mg/day, Trimebutine maleate

improved symptoms related to dyspepsia; its efficacy was similar to that of metoclopramide.''"237 Trimebutine maleate and pathological states of intestinal motility in a double-blind controlled study, Trimebutine maleate (400 mg, intravenously) shortened the period of postoperative ileus in patients who had undergone abdominal surgery. 109 in patients with idiopathic intestinal pseudo-obstruction, Trimebutine maleate (100 mg,intravenously) induced phase iii ofthe mmc,

despite the absence of any spontaneous phase iii in these patients.p"